News

Goldman Sachs Adjusts Procter & Gamble Forecast Amid Global Issues

Goldman Sachs Adjusts Procter & Gamble Forecast Amid Global Issues

Goldman Sachs Adjustments to Procter & Gamble Forecast

Procter & Gamble Company (NYSE: PG) has come under increasing scrutiny as Goldman Sachs analyst Bonnie Herzog has adjusted the company's first-quarter estimates. This revision reflects a trend of softer end markets, particularly in some international regions. The anticipated adjustments highlight persistent global challenges impacting one of the world's leading consumer goods enterprises.

Revised Estimates and Price Target

Herzog has set a new price target of $164 for PG, adjusting it downward from $165 while maintaining a Neutral rating. This slight change illustrates the cautious stance analysts are taking amid current market conditions. Despite some resilience reported in scanner trends suggesting continued growth in the U.S. market, international difficulties in locations such as the Middle East and China are expected to hinder overall performance.

Market Performance and Growth Expectations

In addition to these challenges, Herzog anticipates a prolonged recovery for the SK-II brand, projecting no significant shifts until late 2024. At this juncture, it is hoped that negative perceptions toward Japanese brands may decline, allowing for renewed consumer interest and sales. In the meantime, for the first quarter, an organic sales growth of approximately 2% is expected. However, this growth may be impeded by foreign exchange translation headwinds, resulting in net sales growth remaining flat.

Analyzing Gross Margins and Earnings Potential

The analyst forecasts a slight expansion in gross margins, supporting year-over-year earnings per share (EPS) growth of 4.7% to $1.91, down from a previous estimate of $1.96. The cautious outlook is primarily due to the challenges facing Procter & Gamble within their end markets, compounded by a slowdown to 2% growth observed in the fourth quarter. This shift in expectations has informed investor sentiment to lean towards the lower end of PG’s FY25 organic sales growth guidance of 3%-5%, contrasted with consensus estimates hovering around 3.5% and 3.6%.

Long-term Earnings and Investor Considerations

Further analysis indicates that productivity gains may yield an estimated EPS compound annual growth rate (CAGR) exceeding 5% from FY24 to FY27. This projection is a subtle decline from previous rates of approximately 6.5% CAGR. Investors remain apprehensive, given that PG's organic sales growth has seen a deceleration in recent quarters while the stock continues to trade at elevated multiples. This scenario fosters a cautious atmosphere for both potential and current investors.

Investor Opportunities Through ETFs

For those looking to invest in Procter & Gamble, exposure can be attained through various exchange-traded funds. In particular, the iShares U.S. Consumer Staples ETF (NYSE: IYK) and Vanguard Consumer Staples ETF (NYSE: VDC) provide avenues for diversified investment in consumer staples, including Procter & Gamble.

Current Stock Performance

As of the latest update, shares of Procter & Gamble are down 0.93%, trading at $167.31. This recent decline reflects broader market conditions and investor sentiment regarding the company’s upcoming challenges and revisions in forecast.

Frequently Asked Questions

What recent changes did Goldman Sachs make to PG's evaluation?

Goldman Sachs lowered Procter & Gamble's first-quarter estimates, adjusting the price target down to $164.

What challenges is Procter & Gamble facing internationally?

Procter & Gamble is encountering difficulties in markets such as the Middle East and China, which are affecting global performance.

How does PEG's EPS growth forecast look?

The current forecast suggests EPS growth of 4.7% to $1.91 for the coming year, though it has been downgraded from earlier estimates.

Which ETFs provide exposure to Procter & Gamble?

Investors can gain exposure through the iShares U.S. Consumer Staples ETF (IYK) and the Vanguard Consumer Staples ETF (VDC).

What is the current trading status of PG shares?

PG shares recently showed a decline, trading at $167.31, reflecting ongoing investor caution amid global challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 8

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 6

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 5

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 12

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Against Rentokil Initial plc Highlights Investor Concerns

Updated Category News Views 247

Severe Market Implications for Rentokil Initial plc Rentokil Initial plc is currently facing a significant class action lawsuit that underscores serious investor concerns. This legal challenge centers on alleged securities law violations, which have raised red flags among shareholders of the company. In light of the ongoing situation, it is vital for investors to remain...

Continue Reading
Pet Care Primer: Insights from Dr. Ashley Deforno

Updated Category News Views 109

So here’s the scoop: First-time pet owners in Blairsville got a solid guide dropped by Dr. Ashley Deforno of East Market Veterinary Center on Feb 17, 2026. The guidance focuses on what you need to know before bringing home a new furry friend—everything from finding the right vet to understanding those essential early vaccinations. First Steps: Choosing a Vet and...

Continue Reading
Homeowners Unite Against Monroe Capital's Alleged Lending Scheme

Updated Category News Views 549

Homeowners Take Action Against Alleged Predatory Lending In a significant legal move, homeowners across the nation have initiated a class action lawsuit targeting Monroe Capital Corporation. This lawsuit brings to light serious accusations against Monroe Capital for its alleged role in financing a deceptive lending scheme that has reportedly defrauded approximately 38,000...

Continue Reading
Insights into the Growing Digital Therapeutics Landscape

Updated Category News Views 71

Exploring the Growth of the Digital Therapeutics Market In recent years, the digital therapeutics market has experienced significant growth. Projections suggest it will expand from USD 1,035.6 million in 2023 to USD 1,805.6 million by 2031. This appealing market is expected to grow at a compound annual growth rate (CAGR) of 7.2% between 2024 and 2031. A key element...

Continue Reading
Kytopen Strengthens Board with Experienced Leaders for Growth

Updated Category News Views 188

Kytopen Strengthens Board with Industry Expertise Kytopen has recently made significant strides in its commercial journey by appointing two renowned industry veterans to its Board of Directors. This strategic move aligns with the company's vision for commercial expansion of its Flowfect Tx GMP cellular engineering platform. The addition of experienced leaders promises to...

Continue Reading